March 27, 2023
Medical Device Network
Biocept begins subject enrolment in CNSide assay trial
The trial will assess CNSide's performance in tracking the response of leptomeningeal metastases to t... See more »
Myriad: Myriad Genetics Focuses on Expanding Access, Collaboration and Equity in Genetic Testing at National Society of Genetic Counselors Meeting
(marketscreener.com) SALT LAKE CITY, Nov. 14, 2022 -- Myriad Genetics, Inc., , a leader in genetic testing and precision medicine, will spotlight efforts to expand access to prenatal and hereditary cancer genetic insights at the 41st Annual National Society of Genetic Counselors meeting, Nov. 16-19 in Nashville, Tenn. "In today's patient-centric...https://www.marketscreener.com/quote/stock/MYRIAD-GENETICS-INC-10141/news/Myriad-Genetics-Focuses-on-Expanding-Access-Collaboration-and-Equity-in-Genetic-Testing-at-National-42306345/?utm_medium=RSS&utm_content=20221114
Read full article »
March 25, 2023
Life Care News
23andMe Aims To Raise Awareness of Lipoprotein(a), a
Continue reading 23andMe Aims To Raise Awareness of Lipoprotein(a), a at LifeCareNews.... See more »
March 27, 2023
23andMe Blog
A Name and a Necklace
A name, a letter, and a necklace, that’s all Julia had of her birth mother for 22 years. ̶... See more »
March 27, 2023
Medical Device Network
Biocept begins subject enrolment in CNSide assay trial
The trial will assess CNSide's performance in tracking the response of leptomeningeal metastases to t... See more »
March 25, 2023
Life Care News
23andMe Aims To Raise Awareness of Lipoprotein(a), a
Continue reading 23andMe Aims To Raise Awareness of Lipoprotein(a), a at LifeCareNews.... See more »
March 27, 2023
23andMe Blog
A Name and a Necklace
A name, a letter, and a necklace, that’s all Julia had of her birth mother for 22 years. ̶... See more »
Myriad is an Utah-based healthcare company that discovers and commercializes molecular diagnostic tests and equipments for inherited diseases.
Read more